# Waste Management Inc: financial statements, quarterly

WM · NYSE · CIK 823768 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wm.md) · [Financials](/companies/wm/financials.md) · [Filings](/companies/wm/filings.md) · [Insiders](/companies/wm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,198](/filings/0001558370-24-013762.md) | [5,217 d](/filings/0001104659-26-012049.md) | [5,159](/filings/0001558370-25-005805.md) | [5,402](/filings/0001558370-25-009726.md) | [5,609](/filings/0001104659-25-103136.md) | [5,893 d](/filings/0001104659-26-012049.md) | [6,018](/filings/0001104659-26-051283.md) | [6,430](/filings/0001104659-26-088016.md) | [6,443](/filings/0001104659-25-103136.md) | [6,313 d](/filings/0001104659-26-012049.md) | [6,227](/filings/0001104659-26-051283.md) | [6,684](/filings/0001104659-26-088016.md) |
| Cost of revenue | $m | [3,188](/filings/0001558370-24-013762.md) | [3,146 d](/filings/0001104659-26-012049.md) | [3,140](/filings/0001558370-25-005805.md) | [3,291](/filings/0001558370-25-009726.md) | [3,399](/filings/0001104659-25-103136.md) | [3,553 d](/filings/0001104659-26-012049.md) | [3,612](/filings/0001104659-26-051283.md) | [3,803](/filings/0001104659-26-088016.md) | [3,833](/filings/0001104659-25-103136.md) | [3,693 d](/filings/0001104659-26-012049.md) | [3,694](/filings/0001104659-26-051283.md) | [3,955](/filings/0001104659-26-088016.md) |
| Selling, general and administrative | $m | [470](/filings/0001558370-24-013762.md) | [513 d](/filings/0001104659-26-012049.md) | [491](/filings/0001558370-25-005805.md) | [501](/filings/0001558370-25-009726.md) | [525](/filings/0001104659-25-103136.md) | [747 d](/filings/0001104659-26-012049.md) | [687](/filings/0001104659-26-051283.md) | [696](/filings/0001104659-26-088016.md) | [665](/filings/0001104659-25-103136.md) | [674 d](/filings/0001104659-26-012049.md) | [707](/filings/0001104659-26-051283.md) | [683](/filings/0001104659-26-088016.md) |
| Operating income | $m | [1,021](/filings/0001558370-24-013762.md) | [785 d](/filings/0001104659-26-012049.md) | [1,016](/filings/0001558370-25-005805.md) | [1,009](/filings/0001558370-25-009726.md) | [1,119](/filings/0001104659-25-103136.md) | [919 d](/filings/0001104659-26-012049.md) | [1,013](/filings/0001104659-26-051283.md) | [1,151](/filings/0001104659-26-088016.md) | [989](/filings/0001104659-25-103136.md) | [1,155 d](/filings/0001104659-26-012049.md) | [1,113](/filings/0001104659-26-051283.md) | [1,253](/filings/0001104659-26-088016.md) |
| Income tax | $m | [210](/filings/0001558370-24-013762.md) | [175 d](/filings/0001104659-26-012049.md) | [162](/filings/0001558370-25-005805.md) | [214](/filings/0001558370-25-009726.md) | [235](/filings/0001104659-25-103136.md) | [102 d](/filings/0001104659-26-012049.md) | [151](/filings/0001104659-26-051283.md) | [201](/filings/0001104659-26-088016.md) | [172](/filings/0001104659-25-103136.md) | [193 d](/filings/0001104659-26-012049.md) | [168](/filings/0001104659-26-051283.md) | [238](/filings/0001104659-26-088016.md) |
| Net income | $m | [663](/filings/0001558370-24-013762.md) | [493 d](/filings/0001104659-26-012049.md) | [708](/filings/0001558370-25-005805.md) | [680](/filings/0001558370-25-009726.md) | [760](/filings/0001104659-25-103136.md) | [598 d](/filings/0001104659-26-012049.md) | [637](/filings/0001104659-26-051283.md) | [726](/filings/0001104659-26-088016.md) | [603](/filings/0001104659-25-103136.md) | [742 d](/filings/0001104659-26-012049.md) | [723](/filings/0001104659-26-051283.md) | [785](/filings/0001104659-26-088016.md) |
| Diluted EPS | $ per share | [1.63](/filings/0001558370-24-013762.md) | not reported | [1.75](/filings/0001558370-25-005805.md) | [1.69](/filings/0001558370-25-009726.md) | [1.88](/filings/0001104659-25-103136.md) | not reported | [1.58](/filings/0001104659-26-051283.md) | [1.80](/filings/0001104659-26-088016.md) | [1.49](/filings/0001104659-25-103136.md) | not reported | [1.79](/filings/0001104659-26-051283.md) | [1.95](/filings/0001104659-26-088016.md) |
| Basic EPS | $ per share | [1.64](/filings/0001558370-24-013762.md) | not reported | [1.76](/filings/0001558370-25-005805.md) | [1.70](/filings/0001558370-25-009726.md) | [1.89](/filings/0001104659-25-103136.md) | not reported | [1.58](/filings/0001104659-26-051283.md) | [1.80](/filings/0001104659-26-088016.md) | [1.50](/filings/0001104659-25-103136.md) | not reported | [1.79](/filings/0001104659-26-051283.md) | [1.96](/filings/0001104659-26-088016.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001558370-24-013762.md) | [0.5](/filings/0001104659-26-012049.md) | [0.3](/filings/0001558370-25-005805.md) | [0.2](/filings/0001558370-25-009726.md) | [0.6](/filings/0001104659-25-103136.md) | [0.4](/filings/0001104659-26-012049.md) | [0.2](/filings/0001104659-26-051283.md) | [0.4](/filings/0001104659-26-088016.md) | [0.2](/filings/0001104659-25-103136.md) | [0.2](/filings/0001104659-26-088016.md) | [0.2](/filings/0001104659-26-051283.md) | [0.6](/filings/0001104659-26-088016.md) |
| Current assets | $bn | [3.6](/filings/0001558370-23-016700.md) | [3.8](/filings/0001558370-25-001132.md) | [3.5](/filings/0001558370-24-005734.md) | [4.4](/filings/0001558370-24-010155.md) | [4.3](/filings/0001558370-24-013762.md) | [4.8](/filings/0001104659-26-012049.md) | [4.5](/filings/0001558370-25-005805.md) | [5.0](/filings/0001558370-25-009726.md) | [4.8](/filings/0001104659-25-103136.md) | [4.9](/filings/0001104659-26-088016.md) | [4.8](/filings/0001104659-26-051283.md) | [5.4](/filings/0001104659-26-088016.md) |
| Total assets | $bn | [31.9](/filings/0001558370-23-016700.md) | [32.8](/filings/0001558370-25-001132.md) | [32.7](/filings/0001558370-24-005734.md) | [34.0](/filings/0001558370-24-010155.md) | [34.7](/filings/0001558370-24-013762.md) | [44.6](/filings/0001104659-26-012049.md) | [44.5](/filings/0001558370-25-005805.md) | [45.7](/filings/0001558370-25-009726.md) | [45.6](/filings/0001104659-25-103136.md) | [45.8](/filings/0001104659-26-088016.md) | [45.7](/filings/0001104659-26-051283.md) | [46.4](/filings/0001104659-26-088016.md) |
| Current liabilities | $bn | [4.2](/filings/0001558370-23-016700.md) | [4.2](/filings/0001558370-25-001132.md) | [3.9](/filings/0001558370-24-005734.md) | [4.1](/filings/0001558370-24-010155.md) | [4.8](/filings/0001558370-24-013762.md) | [6.3](/filings/0001104659-26-012049.md) | [5.3](/filings/0001558370-25-005805.md) | [5.8](/filings/0001558370-25-009726.md) | [5.7](/filings/0001104659-25-103136.md) | [5.5](/filings/0001104659-26-088016.md) | [5.1](/filings/0001104659-26-051283.md) | [5.9](/filings/0001104659-26-088016.md) |
| Total liabilities | $bn | [25.0](/filings/0001558370-23-016700.md) | [25.9](/filings/0001558370-25-001132.md) | [25.6](/filings/0001558370-24-005734.md) | [26.5](/filings/0001558370-24-010155.md) | [26.8](/filings/0001558370-24-013762.md) | [36.3](/filings/0001104659-26-012049.md) | [35.8](/filings/0001558370-25-005805.md) | [36.5](/filings/0001558370-25-009726.md) | [36.1](/filings/0001104659-25-103136.md) | [35.8](/filings/0001104659-26-088016.md) | [35.7](/filings/0001104659-26-051283.md) | [36.5](/filings/0001104659-26-088016.md) |
| Current portion of debt | $bn | [0.3](/filings/0001558370-23-016700.md) | [0.3](/filings/0001558370-25-001132.md) | [0.3](/filings/0001558370-24-005734.md) | [0.2](/filings/0001558370-24-010155.md) | [0.7](/filings/0001558370-24-013762.md) | [1.4](/filings/0001104659-26-012049.md) | [1.0](/filings/0001558370-25-005805.md) | [1.0](/filings/0001558370-25-009726.md) | [0.9](/filings/0001104659-25-103136.md) | [0.7](/filings/0001104659-26-088016.md) | [0.6](/filings/0001104659-26-051283.md) | [1.1](/filings/0001104659-26-088016.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [7.0](/filings/0001558370-23-016700.md) | [6.9](/filings/0001558370-25-001132.md) | [7.1](/filings/0001558370-24-005734.md) | [7.5](/filings/0001558370-24-010155.md) | [8.0](/filings/0001558370-24-013762.md) | [8.3](/filings/0001104659-26-012049.md) | [8.7](/filings/0001558370-25-005805.md) | [9.2](/filings/0001558370-25-009726.md) | [9.5](/filings/0001104659-25-103136.md) | [10.0](/filings/0001104659-26-088016.md) | [10.0](/filings/0001104659-26-051283.md) | [9.9](/filings/0001104659-26-088016.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,263 d](/filings/0001558370-24-013762.md) | [1,382 d](/filings/0001104659-26-012049.md) | [1,367](/filings/0001558370-25-005805.md) | [1,154 d](/filings/0001558370-25-009726.md) | [1,358 d](/filings/0001104659-25-103136.md) | [1,511 d](/filings/0001104659-26-012049.md) | [1,208](/filings/0001104659-26-051283.md) | [1,545 d](/filings/0001104659-26-088016.md) | [1,592 d](/filings/0001104659-25-103136.md) | [1,698 d](/filings/0001104659-26-012049.md) | [1,501](/filings/0001104659-26-051283.md) | [1,726 d](/filings/0001104659-26-088016.md) |
| Capital expenditure | $m | [673 d](/filings/0001558370-24-013762.md) | [1,042 d](/filings/0001104659-26-012049.md) | [668](/filings/0001558370-25-005805.md) | [667 d](/filings/0001558370-25-009726.md) | [781 d](/filings/0001104659-25-103136.md) | [1,115 d](/filings/0001104659-26-012049.md) | [831](/filings/0001104659-26-051283.md) | [732 d](/filings/0001104659-26-088016.md) | [776 d](/filings/0001104659-25-103136.md) | [888 d](/filings/0001104659-26-012049.md) | [650](/filings/0001104659-26-051283.md) | [630 d](/filings/0001104659-26-088016.md) |
| Dividends paid | $m | [283 d](/filings/0001558370-24-013762.md) | [281 d](/filings/0001104659-26-012049.md) | [307](/filings/0001558370-25-005805.md) | [301 d](/filings/0001558370-25-009726.md) | [301 d](/filings/0001104659-25-103136.md) | [301 d](/filings/0001104659-26-012049.md) | [336](/filings/0001104659-26-051283.md) | [333 d](/filings/0001104659-26-088016.md) | [332 d](/filings/0001104659-25-103136.md) | [333 d](/filings/0001104659-26-012049.md) | [385](/filings/0001104659-26-051283.md) | [379 d](/filings/0001104659-26-088016.md) |
| Share repurchases | $m | [370 d](/filings/0001558370-24-013762.md) | [312 d](/filings/0001104659-26-012049.md) | [250](/filings/0001558370-25-005805.md) | [12.0 d](/filings/0001558370-25-009726.md) | [0.0 d](/filings/0001104659-25-103136.md) | [0.0 d](/filings/0001104659-26-012049.md) | not reported | not reported | not reported | not reported | [344](/filings/0001104659-26-051283.md) | [659 d](/filings/0001104659-26-088016.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [414](/filings/0001558370-23-016700.md) | [409](/filings/0001558370-24-005734.md) | [408](/filings/0001558370-24-010155.md) | [406](/filings/0001558370-24-013762.md) | [404](/filings/0001558370-25-005805.md) | [403](/filings/0001558370-25-009726.md) | [403](/filings/0001104659-25-103136.md) | [404](/filings/0001104659-26-051283.md) | [404](/filings/0001104659-26-088016.md) | [404](/filings/0001104659-25-103136.md) | [404](/filings/0001104659-26-051283.md) | [402](/filings/0001104659-26-088016.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 399,715,184 at 2026-07-24, from the cover of the [10-Q filed 2026-07-29](/filings/0001104659-26-088016.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.